Parenchyma Biotech Co., Ltd. announced that it will issue 100,000 shares for gross proceeds of KRW 500,000,000 on August 13, 2019. The transaction will include participation from SLS BIO Co., Ltd (XKON:A246250). The investor will hold 45% stake in the company. The transaction has been approved by the board of directors of the investor.